A recent study suggests that certain weight loss medications may lead to hair loss. The research, which involved 50,000 users of weight loss injections like Wegovy and Mounjaro, found a potential connection to a rare side effect known as alopecia.
Individuals taking appetite-suppressing medications have reported hair loss to regulatory bodies, prompting investigation into whether the drugs themselves are causing this issue. Although the overall risk is deemed low, an analysis of patient data from the University of Pennsylvania Health System indicates a likely association.
According to findings published in the British Medical Journal, patients using weight loss drugs were 68% more likely to experience hair loss compared to those using different diabetes medications. Experts suggest that hair loss could be triggered by sudden reductions in calorie intake and deficiencies in essential nutrients. The US Food and Drug Administration is currently looking into this potential side effect.
Dr. Yong Chen from the University of Pennsylvania explained that weight loss and changes in nutritional status are known risk factors for a type of non-scarring hair loss called telogen effluvium. While hair loss may not pose physical harm, it can have significant psychological effects on self-esteem, quality of life, and treatment adherence.
The study revealed a link to non-scarring alopecia, where hair follicles remain intact, allowing for potential regrowth. However, it did not confirm whether hair would fully grow back. Drugs like Ozempic, Wegovy, and Mounjaro, administered through weekly injections, work by slowing digestion and curbing appetite by mimicking a hormone called glucagon-like peptide 1 (GLP-1) that regulates hunger and satiety.
In light of these findings, some experts, including Dr. Amir Khan from Good Morning Britain, advocate for alternative weight loss methods. Research focused on individuals with type 2 diabetes using GLP-1 drugs or other diabetes medications revealed a higher risk of alopecia with the former. Despite this potential side effect, the benefits of GLP-1 receptor agonists in managing blood sugar levels, reducing weight, and preventing obesity-related complications are well-established.
While GLP-1 drugs have shown positive effects, they may also lead to side effects like vomiting and constipation. Proper support from healthcare professionals is crucial to ensure effective weight loss maintenance. While medications like Mounjaro and Wegovy are prescribed by the NHS for weight loss purposes, Ozempic is typically used to treat diabetes.